Genetic Technologies (NSDQ:GENE) settled a lawsuit against Hologic Inc. (NSDQ:HOLX) over one of its gene testing patents, leaving seven other defendants in the suit.
Women’s health firm Hologic was one of nine original defendants in the lawsuit. The settlement involves the licensing of the patent to Hologic in return for undisclosed financial terms, according to a regulatory filing.
In April, Genetic Technologies settled another lawsuit it brought in 2010 over the same patent against Beckman Coulter and seven other firms.
Sign up to get our free newsletters delivered straight to your inbox
In June, the Australian gene testing firm settled with Navigenics under similar terms, according to a filing with the federal Securities & Exchange Commission.
“With the settlement of both Navigenics and now Hologic, the company is pleased with the tempo and progress of this third assertion suit,” said CEO Paul MacLeman said in prepared remarks.
Read more medical device legal news from MassDevice.com
Nomir Medical settles malpractice suit with McDermott Will & Emery
Nomir Medical Technologies settled a lawsuit it filed against its former patent law firm that had accused McDermott, Will & Emery of malpractice that cost the optical device firm $143 million.
Waltham, Mass.-based Nomir sued MWE in July 2010, accusing the law firm of “negligence, fraud, negligent misrepresentations, breach of fiduciary duty, breach of contract, breach of the implied covenant of good faith and fair dealing and unfair and deceptive practices,” according to court documents, for failing to file documents with the U.S. Patent and Trademark Office needed to protect Nomir’s intellectual property.
In its response, filed in the U.S. District Court for Massachusetts, the law firm denied the accusations and accused Nomir of failing to pay nearly $500,000 in legal bills.
Now the case has been settled with prejudice, meaning either side can re-file if their agreement isn’t consummated within 30 days, and with each side bearing its own legal costs, according to court documents.
